US FDA oversight of investigators' financial conflicts falls short
This article was originally published in Scrip
Executive Summary
The US FDAis not adequately policing the potential for financial conflicts of interest involving outside clinical investigators, according to a new report released by the health and human services department's office of the inspector general (OIG).